Li Hui Chang
Directeur Financier/CFO chez FORMOSA OPTICAL TECHNOLOGY CO.,LTD.
Postes actifs de Li Hui Chang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Comptroller/Controller/Auditor | 06/11/1995 | - |
| Directeur Financier/CFO | 06/11/1995 | - | |
| Investor Relations Contact | - | - | |
| Public Communications Contact | - | - | |
| POLYLITE TAIWAN CO., LTD. | Directeur/Membre du Conseil | 01/06/2006 | - |
Essilor Amera Pte Ltd.
 Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Li Hui Chang
Formation de Li Hui Chang
| Fu Jen Catholic University | Undergraduate Degree |
Statistiques
Internationale
| Taïwan | 4 |
| Singapour | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 3 |
| Process Industries | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Health Technology |
| POLYLITE TAIWAN CO., LTD. | Process Industries |
| Entreprise privées | 1 |
|---|---|
Essilor Amera Pte Ltd.
Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Health Technology |
- Bourse
- Insiders
- Li Hui Chang
- Expérience
